Insider Trading activities of Watson Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Watson Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Watson Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Watson Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is WPI. The reporting company's CIK number is 884629.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $77,610,134.
The total value of stock option exercises since 2005 is $61,875,587.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Watson Pharmaceuticals Inc (WPI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-09 0 $0 29,013 $4,011,923 232,961 $19,543,500
2013-08 0 $0 168,963 $22,823,035 579,200 $17,718,682
2013-03 0 $0 23,913 $2,109,908 8,000 $311,360
2012-08 0 $0 39,618 $3,202,494 38,250 $1,170,959
2012-07 0 $0 51,700 $4,064,246 51,700 $1,844,231
2012-06 0 $0 25,000 $1,746,100 20,000 $663,750
2012-05 0 $0 107,146 $7,870,961 115,005 $3,765,532
2012-02 0 $0 4,981 $292,837 1,000 $25,640
2011-12 0 $0 2,000 $126,640 0 $0
2011-11 0 $0 10,000 $657,600 10,000 $368,000
2011-09 0 $0 34,000 $2,257,710 20,000 $532,000
2011-08 0 $0 33,510 $2,183,002 35,248 $989,781
2011-07 0 $0 7,202 $492,688 7,500 $481,350
2011-06 0 $0 2,635 $169,825 0 $0
2011-05 0 $0 30,018 $1,903,511 19,500 $720,610
2011-03 0 $0 50,478 $2,854,664 46,497 $1,884,219
2011-02 0 $0 30,000 $1,649,400 30,000 $1,454,400
2010-12 0 $0 111,366 $5,601,574 112,500 $3,849,787
2010-11 0 $0 4,000 $193,760 0 $0
2010-08 0 $0 29,652 $1,251,210 0 $0
2010-06 0 $0 27,001 $1,141,452 17,000 $483,395
2010-03 0 $0 62,850 $2,562,238 62,850 $1,923,082
2009-12 0 $0 64,654 $2,476,168 54,653 $1,501,559
2008-05 0 $0 100,000 $2,864,800 0 $0
2007-09 0 $0 200,000 $0 0 $0
2007-06 0 $0 0 $0 100,000 $2,437,500
2006-08 0 $0 0 $0 15,000 $206,250
2005-12 0 $0 17,000 $565,726 0 $0
2005-11 0 $0 27,400 $898,568 0 $0
2005-09 0 $0 40,000 $1,416,720 0 $0
2005-06 0 $0 4,049 $125,659 0 $0
2005-03 0 $0 3,000 $95,715 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Watson Pharmaceuticals Inc insiders (WPI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-09-30 Fridriksdottir Hafrun (Sr VP, Global Generics R&D) Option Ex 5,110 .00 0
2013-09-30 Eagan Patrick (Chief HR Officer - Global) Option Ex 2,851 .00 0
2013-09-30 Olafsson Sigurdur O (Pres.-Global Generics) Option Ex 150,000 86.86 13,029,000
2013-09-30 Stewart Robert A (Pres-Global Operations) Option Ex 75,000 86.86 6,514,500
2013-09-16 Hummel Albert F Sale 6,200 137.81 854,397
2013-09-04 Wilkinson George Fred (Pres-Global Brands&Biosimilars) Sale 16,749 138.00 2,311,362
2013-09-04 Michelson Jack Sale 6,064 139.54 846,164
2013-08-29 Buchen David A (Chief Legal Officer-Global&Sec) Sale 10,000 135.56 1,355,580
2013-08-29 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 10,000 30.38 303,750
2013-08-26 Hummel Albert F Sale 15,956 134.44 2,145,140
2013-08-23 Hummel Albert F Sale 4,044 134.16 542,551
2013-08-22 Hummel Albert F Sale 20,000 134.50 2,689,920
2013-08-20 Bisaro Paul (President & CEO) Sale 50,000 135.30 6,765,100
2013-08-15 Paonessa Albert Iii (President of Anda, Inc.) Sale 5,476 135.89 744,111
2013-08-14 Joyce R Todd (CFO-Global) Sale 15,000 138.10 2,071,500
2013-08-13 Hummel Albert F Sale 10,000 133.85 1,338,520
2013-08-13 Hummel Albert F Option Ex 10,000 29.58 295,750
2013-08-12 Mayr Charles M (Chief Communic Off-Global) Sale 4,820 133.23 642,168
2013-08-12 Buchen David A (Chief Legal Officer-Global&Sec) Sale 16,800 133.01 2,234,534
2013-08-12 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 16,800 26.14 439,152
2013-08-12 Klema Cathy Sale 1,667 133.03 221,766
2013-08-09 Buchen David A (Chief Legal Officer-Global&Sec) Sale 200 135.00 27,000
2013-08-09 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 200 26.14 5,228
2013-08-09 Taylor Ronald R Sale 5,000 135.14 675,705
2013-08-09 Taylor Ronald R Option Ex 5,000 29.03 145,150
2013-08-07 Bisaro Paul (President & CEO) Option Ex 527,200 30.66 16,163,952
2013-08-05 Feldman Michel J Sale 10,000 136.94 1,369,440
2013-08-05 Feldman Michel J Option Ex 10,000 36.57 365,700
2013-03-14 Mayr Charles M (Chief Communic Off-Global) Sale 1,000 91.77 91,770
2013-03-12 Buchen David A (Chief Legal Officer-Global&Sec) Sale 8,000 89.00 712,000
2013-03-12 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 8,000 38.92 311,360
2013-03-12 Fedida Michael J Sale 8,000 89.00 712,000
2013-03-05 Paonessa Albert Iii (President of Anda, Inc.) Sale 4,413 86.05 379,738
2013-03-04 Turner Andrew L Sale 2,500 85.76 214,400
2012-08-30 Feldman Michel J Sale 5,500 81.62 448,910
2012-08-24 Buchen David A (Chief Legal Officer-Global&Sec) Sale 24,294 81.56 1,981,418
2012-08-24 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 25,000 29.43 735,750
2012-08-01 Joyce R Todd (CFO-Global & PAO) Sale 9,824 78.60 772,166
2012-08-01 Joyce R Todd (CFO-Global & PAO) Option Ex 13,250 32.85 435,209
2012-07-31 Klema Cathy Sale 21,700 78.38 1,700,846
2012-07-31 Klema Cathy Option Ex 21,700 34.43 747,131
2012-07-30 Weiss Fred G Sale 30,000 78.78 2,363,400
2012-07-30 Weiss Fred G Option Ex 30,000 36.57 1,097,100
2012-06-08 Fedida Michael J Sale 5,000 70.04 350,200
2012-06-08 Fedida Michael J Option Ex 10,000 29.58 295,750
2012-06-07 Michelson Jack Sale 20,000 69.80 1,395,900
2012-06-07 Michelson Jack Option Ex 10,000 36.80 368,000
2012-05-30 Taylor Ronald R Sale 30,000 72.58 2,177,400
2012-05-30 Taylor Ronald R Option Ex 30,000 36.80 1,104,000
2012-05-29 Menard Francois A (SVP,Global Generics R&D) Sale 3,467 73.89 256,176
2012-05-29 Hummel Albert F Sale 19,000 73.74 1,401,060
2012-05-29 Turner Andrew L Sale 20,000 73.59 1,471,800
2012-05-29 Turner Andrew L Option Ex 20,000 36.80 736,000
2012-05-25 Joyce R Todd (CFO-Global & PAO) Option Ex 5 26.40 132
2012-05-25 Buchen David A (Chief Legal Officer-Global&Sec) Option Ex 15,000 26.40 396,000
2012-05-08 Paonessa Albert Iii (President of Anda, Inc.) Sale 4,000 72.77 291,084
2012-05-07 Feldman Michel J Sale 20,000 73.77 1,475,400
2012-05-07 Feldman Michel J Option Ex 20,000 36.57 731,400
2012-05-02 Hummel Albert F Sale 10,679 74.73 798,041
2012-05-02 Hummel Albert F Option Ex 30,000 26.60 798,000
2012-02-29 Ebert Charles D (Sr. VP, Research & Development) Sale 4,981 58.79 292,837
2012-02-29 Ebert Charles D (Sr. VP, Research & Development) Option Ex 1,000 25.64 25,640
2011-12-02 Fedida Michael J Sale 2,000 63.32 126,640
2011-11-15 Turner Andrew L Sale 10,000 65.76 657,600
2011-11-15 Turner Andrew L Option Ex 10,000 36.80 368,000
2011-09-16 Hummel Albert F Sale 10,000 67.25 672,510
2011-09-16 Fedida Michael J Option Ex 20,000 26.60 532,000
2011-09-14 Fedida Michael J Sale 20,000 66.08 1,321,600
2011-09-14 Turner Andrew L Sale 4,000 65.90 263,600
2011-08-29 Paonessa Albert Iii (EVP & COO of Anda, Inc.) Sale 1,517 66.20 100,417
2011-08-26 Buchen David A (Exec VP,General Counsel & Sec.) Sale 17,500 65.50 1,146,250
2011-08-26 Buchen David A (Exec VP,General Counsel & Sec.) Option Ex 17,500 28.15 492,625
2011-08-24 Joyce R Todd (Exec Vice Pres. & CFO) Sale 9,540 65.46 624,488
2011-08-24 Joyce R Todd (Exec Vice Pres. & CFO) Option Ex 17,748 28.01 497,156
2011-08-15 Turner Andrew L Sale 1,000 64.74 64,745
2011-08-05 Menard Francois A (SVP,Generics R&D) Sale 3,953 62.51 247,102
2011-07-27 Joyce R Todd (Exec Vice Pres. & CFO) Sale 7,202 68.41 492,688
2011-07-27 Joyce R Todd (Exec Vice Pres. & CFO) Option Ex 7,500 64.18 481,350
2011-06-01 Ebert Charles D (Sr. VP, Research & Development) Sale 2,635 64.45 169,825
2011-05-27 Buchen David A (Exec VP,General Counsel & Sec.) Sale 7,000 64.10 448,699
2011-05-27 Buchen David A (Exec VP,General Counsel & Sec.) Option Ex 7,000 54.48 381,360
2011-05-06 Hummel Albert F Sale 15,000 63.36 950,400
2011-05-04 Joyce R Todd (Exec Vice Pres. & CFO) Sale 8,018 62.91 504,412
2011-05-04 Joyce R Todd (Exec Vice Pres. & CFO) Option Ex 12,500 27.14 339,250
2011-03-17 Paonessa Albert Iii (EVP & COO of Anda, Inc.) Sale 2,000 54.59 109,180
2011-03-10 Michelson Jack Sale 25,000 56.42 1,410,500
2011-03-10 Michelson Jack Option Ex 20,000 36.80 736,000
2011-03-03 Joyce R Todd (Sr Vice Pres. & CFO) Sale 10,978 57.09 626,734
2011-03-03 Joyce R Todd (Sr Vice Pres. & CFO) Option Ex 13,997 38.39 537,344
2011-03-03 Ebert Charles D (Sr. VP, Research & Development) Sale 7,500 56.36 422,700
2011-03-03 Ebert Charles D (Sr. VP, Research & Development) Option Ex 7,500 48.85 366,375
2011-03-03 Buchen David A (Sr. VP, General Counsel & Sec.) Sale 5,000 57.11 285,550
2011-03-03 Buchen David A (Sr. VP, General Counsel & Sec.) Option Ex 5,000 48.90 244,500
2011-02-23 Feldman Michel J Sale 30,000 54.98 1,649,400
2011-02-23 Feldman Michel J Option Ex 30,000 48.48 1,454,400
2010-12-16 Fedida Michael J Option Ex 10,000 26.60 266,000
2010-12-15 Russillo Thomas R (EVP, Global Generics) Sale 60,000 50.00 3,000,000
2010-12-15 Russillo Thomas R (EVP, Global Generics) Option Ex 60,000 25.86 1,551,600
2010-12-15 Fedida Michael J Sale 5,227 51.07 266,963
2010-12-15 Weiss Fred G Sale 30,000 51.03 1,530,840
2010-12-15 Weiss Fred G Option Ex 30,000 48.48 1,454,400
2010-12-14 Joyce R Todd (Sr Vice Pres. & CFO) Sale 10,000 49.57 495,670
2010-12-14 Joyce R Todd (Sr Vice Pres. & CFO) Option Ex 10,000 46.31 463,100
2010-12-10 Joyce R Todd (Sr Vice Pres. & CFO) Sale 2,500 49.00 122,512
2010-12-10 Joyce R Todd (Sr Vice Pres. & CFO) Option Ex 2,500 45.88 114,687
2010-12-06 Ebert Charles D (Sr. VP, Research & Development) Sale 3,639 51.00 185,589
2010-11-29 Paonessa Albert Iii (EVP & COO of Anda, Inc.) Sale 4,000 48.44 193,760
2010-08-24 Hummel Albert F Sale 20,000 42.07 841,420
2010-08-23 Feldman Michel J Sale 8,334 42.48 354,011
2010-08-16 Carmichael Clare (SR VP, Human Resources) Sale 1,318 42.32 55,779
2010-06-11 Turner Andrew L Sale 5,000 42.58 212,900
2010-06-08 Michelson Jack Sale 22,001 42.20 928,552
2010-06-08 Michelson Jack Option Ex 17,000 28.44 483,395
2010-03-16 Munro Gordon (Sr. VP, Quality Assurance) Sale 29,250 40.61 1,187,842
2010-03-16 Munro Gordon (Sr. VP, Quality Assurance) Option Ex 29,250 30.03 878,377
2010-03-15 Turner Andrew L Sale 5,000 41.12 205,600
2010-03-15 Turner Andrew L Option Ex 5,000 29.03 145,150
2010-03-12 Ebert Charles D (Sr. VP, Research & Development) Sale 28,600 40.87 1,168,796
2010-03-12 Ebert Charles D (Sr. VP, Research & Development) Option Ex 28,600 31.45 899,555
2009-12-16 Giordano Thomas R (Sr VP and CIO) Sale 10,000 38.47 384,700
2009-12-16 Giordano Thomas R (Sr VP and CIO) Option Ex 10,000 25.62 256,200
2009-12-10 Miranda Diane F (VP,Generic Marketing & Oper.) Sale 25,653 38.29 982,330
2009-12-10 Miranda Diane F (VP,Generic Marketing & Oper.) Option Ex 25,653 28.44 729,699
2009-12-10 Ebert Charles D (Sr. VP, Research & Development) Sale 19,000 38.25 726,750
2009-12-10 Ebert Charles D (Sr. VP, Research & Development) Option Ex 19,000 27.14 515,660
2009-12-10 Turner Andrew L Sale 10,001 38.24 382,388
2008-05-15 Hsia David C (Sr. VP, Scientific Affairs) Sale 100,000 28.65 2,864,800
2007-09-14 Chao Allen (Executive Chairman) Sale 90,000 .00 0
2007-09-13 Chao Allen (Executive Chairman) Sale 110,000 .00 0
2007-06-28 Chao Allen (Chairman, President & CEO) Option Ex 100,000 24.38 2,437,500
2006-08-14 Hsia David C (Sr. VP, Scientific Affairs) Option Ex 15,000 13.75 206,250
2005-12-01 Ebert Charles D (Development) Sale 17,000 33.28 565,726
2005-11-22 Ebert Charles D (Development) Sale 12,400 33.18 411,369
2005-11-17 Ebert Charles D (Development) Sale 15,000 32.48 487,199
2005-09-12 Hsia David C (Sr. VP, Scientific A) Sale 40,000 35.42 1,416,720
2005-06-14 Joyce R Todd (Treas.) Sale 1,921 31.35 60,223
2005-06-10 Joyce R Todd (Treas.) Sale 2,128 30.75 65,436
2005-03-09 Feldman Michel J Sale 3,000 31.90 95,715

Insider trading activities including stock purchases, stock sales, and option exercises of WPI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Watson Pharmaceuticals Inc (symbol WPI, CIK number 884629) see the Securities and Exchange Commission (SEC) website.